269 related articles for article (PubMed ID: 16310991)
1. Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.
Altenbach M; Schnyder N; Zimmermann C; Imanidis G
Int J Pharm; 2006 Jan; 307(2):308-17. PubMed ID: 16310991
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transdermal delivery of 5-aminolevulinic acid and a dipeptide by iontophoresis.
Krishnan G; Roberts MS; Grice J; Anissimov YG; Benson HA
Biopolymers; 2011; 96(2):166-71. PubMed ID: 20665477
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
4. Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis.
Akomeah FK; Martin GP; Brown MB
Int J Pharm; 2009 Feb; 367(1-2):162-8. PubMed ID: 18950696
[TBL] [Abstract][Full Text] [Related]
5. Correlation of transdermal iontophoretic phenylalanine and mannitol transport: test of the internal standard concept under DC iontophoresis and constant resistance AC iontophoresis conditions.
Yan G; Higuchi WI; Szabo A; Li SK
J Control Release; 2004 Jul; 98(1):127-38. PubMed ID: 15245895
[TBL] [Abstract][Full Text] [Related]
6. An extended model based on the modified Nernst-Planck equation for describing transdermal iontophoresis of weak electrolytes.
Imanidis G; Luetolf P
J Pharm Sci; 2006 Jul; 95(7):1434-47. PubMed ID: 16724334
[TBL] [Abstract][Full Text] [Related]
7. In vitro transdermal iontophoretic delivery of leuprolide under constant current application.
Kochhar C; Imanidis G
J Control Release; 2004 Jul; 98(1):25-35. PubMed ID: 15245886
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
Yan G; Li SK; Higuchi WI
J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
[TBL] [Abstract][Full Text] [Related]
9. Effects of electrophoresis and electroosmosis during alternating current iontophoresis across human epidermal membrane.
Yan G; Peck KD; Zhu H; Higuchi WI; Li SK
J Pharm Sci; 2005 Mar; 94(3):547-58. PubMed ID: 15637683
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic studies of flux variability of neutral and ionic permeants during constant current dc iontophoresis with human epidermal membrane.
Li SK; Higuchi WI; Kochambilli RP; Zhu H
Int J Pharm; 2004 Apr; 273(1-2):9-22. PubMed ID: 15010125
[TBL] [Abstract][Full Text] [Related]
11. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
12. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude.
Yan G; Xu Q; Anissimov YG; Hao J; Higuchi WI; Li SK
Pharm Res; 2008 Mar; 25(3):616-24. PubMed ID: 17703345
[TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
[TBL] [Abstract][Full Text] [Related]
14. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
Kumar MG; Lin S
Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
[TBL] [Abstract][Full Text] [Related]
16. Enhanced transdermal delivery of a dipeptide by dermaportation.
Namjoshi S; Chen Y; Edwards J; Benson HA
Biopolymers; 2008; 90(5):655-62. PubMed ID: 18536044
[TBL] [Abstract][Full Text] [Related]
17. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
[TBL] [Abstract][Full Text] [Related]
18. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
[TBL] [Abstract][Full Text] [Related]
20. Effect of iontophoresis on skin permeation of defibrase.
Zhao HY; Yuan QP; Zheng JM
Yao Xue Xue Bao; 2005 Feb; 40(2):178-81. PubMed ID: 15875678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
